Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yibei Xiao

Showing results (31-40 of 87) with videos related to

Pageof 9
Sort By:
Journal of Medicinal Chemistry|August 22, 2024
Discovery of Dehydrogenated Imipridone Derivatives as Activators of Human Caseinolytic Protease PJinxin Jiang, Guangjun Xie, Tong Li, et al.
Journal of Medicinal Chemistry|September 7, 2023
Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic AgentsJin Liu, Yao Cheng, Lin Yuan, et al.
Journal of Medicinal Chemistry|May 25, 2022
Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENLYinan Yuan, Lei Du, Rongliang Tan, et al.
Journal of Medicinal Chemistry|February 21, 2022
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and DegradationTianyu Wang, Shi Cai, Yao Cheng, et al.
Journal of Medicinal Chemistry|February 27, 2025
Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer ImmunotherapyZhihao Qi, Yao Cheng, Kaizhen Wang, et al.
Journal of Medicinal Chemistry|December 18, 2023
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling StrategyKaizhen Wang, Xiangyu Zhang, Yao Cheng, et al.
Nucleic Acids Research|January 22, 2026
Structural plasticity enables broad cAn binding and dual activation of CRISPR-associated ribonuclease Cdn1Wenxuan Zhang, Jianping Kong, Yuqin Zeng, et al.
Nature Communications|May 15, 2024
Structure and genome editing of type I-B CRISPR-CasMeiling Lu, Chenlin Yu, Yuwen Zhang, et al.
International Journal of Biological Macromolecules|October 1, 2023
Mammalian trans-editing factor ProX is able to deacylate tRNA<sup>Thr</sup> mischarged with alanineChen Yuan, Zihan Li, Xinyu Luo, et al.
Cell Reports|June 28, 2023
Mechanistic insights into transposon cleavage and integration by TnsB of ShCAST systemTing Zeng, Jie Yin, Ziwen Liu, et al.
Pageof 9

Showing results (31-40 of 87) with videos related to

Sort By:
Pageof 9
Journal of Medicinal Chemistry|August 22, 2024
Discovery of Dehydrogenated Imipridone Derivatives as Activators of Human Caseinolytic Protease PJinxin Jiang, Guangjun Xie, Tong Li, et al.
Journal of Medicinal Chemistry|September 7, 2023
Discovery and Crystallography Study of Novel Biphenyl Ether and Oxadiazole Thioether (Non-Arylmethylamine)-Based Small-Molecule PD-1/PD-L1 Inhibitors as Immunotherapeutic AgentsJin Liu, Yao Cheng, Lin Yuan, et al.
Journal of Medicinal Chemistry|May 25, 2022
Design, Synthesis, and Biological Evaluations of DOT1L Peptide Mimetics Targeting the Protein-Protein Interactions between DOT1L and MLL-AF9/MLL-ENLYinan Yuan, Lei Du, Rongliang Tan, et al.
Journal of Medicinal Chemistry|February 21, 2022
Discovery of Small-Molecule Inhibitors of the PD-1/PD-L1 Axis That Promote PD-L1 Internalization and DegradationTianyu Wang, Shi Cai, Yao Cheng, et al.
Journal of Medicinal Chemistry|February 27, 2025
Discovery, Synthesis, and Activity Evaluation of Novel Small-Molecule Inhibitors Targeting VISTA for Cancer ImmunotherapyZhihao Qi, Yao Cheng, Kaizhen Wang, et al.
Journal of Medicinal Chemistry|December 18, 2023
Discovery of Novel PD-L1 Inhibitors That Induce the Dimerization, Internalization, and Degradation of PD-L1 Based on the Fragment Coupling StrategyKaizhen Wang, Xiangyu Zhang, Yao Cheng, et al.
Nucleic Acids Research|January 22, 2026
Structural plasticity enables broad cAn binding and dual activation of CRISPR-associated ribonuclease Cdn1Wenxuan Zhang, Jianping Kong, Yuqin Zeng, et al.
Nature Communications|May 15, 2024
Structure and genome editing of type I-B CRISPR-CasMeiling Lu, Chenlin Yu, Yuwen Zhang, et al.
International Journal of Biological Macromolecules|October 1, 2023
Mammalian trans-editing factor ProX is able to deacylate tRNA<sup>Thr</sup> mischarged with alanineChen Yuan, Zihan Li, Xinyu Luo, et al.
Cell Reports|June 28, 2023
Mechanistic insights into transposon cleavage and integration by TnsB of ShCAST systemTing Zeng, Jie Yin, Ziwen Liu, et al.
Pageof 9